Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 2Uterine Prolapse 1Urologic Neoplasms 1Renal Insufficiency, Chronic 1Prostatic Neoplasms 1Neuromuscular Blockade 1Leiomyoma 1Intestinal Obstruction 1Esophageal Neoplasms 1Endometriosis 1Endobronchial Metastases 1Cholecystitis 1

Interventions

remimazolam 1Sugammadex 1Rocuronium 1Remifentanil 1Propofol 1Oxycodone 1Flumazenil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Endobronchial Metastases × Rocuronium × Clear all
NCT05468671 2022-10-26

Clinical Application Value of Remazolam Combined With Sugammadex Sodium in Anesthesia for Endotracheal Surgery Under Bronchoscopy

Zhejiang Cancer Hospital

Phase 4 Completed
34 enrolled
GastrointestinalThoracic

Endobronchial Metastases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡